Andreas Reif
Andreas Reif (born 23 July 1971)[1] is a German psychiatrist. He is the head of the Department of Psychiatry, Psychosomatics and Psychotherapy at the University Hospital Frankfurt.[2]
Career
Reif studied medicine at the Julius Maximilian University of Würzburg, where he obtained his doctorate at the Institute of Pharmacology. He completed his residency in psychiatry at the Department of Psychiatry, Psychosomatics and Psychotherapy there, first under H. Beckmann, then under J. Deckert. He established his scientific career in the research group for molecular psychiatry of Klaus-Peter Lesch, focusing predominantly on the genetics of mental disorders. In 2009, he received his habilitation on the role of nitric oxide synthase in mental diseases and was appointed senior physician.[2]
In 2008, he established a clinical focus on bipolar disorders at the Department of Psychiatry, Psychosomatics and Psychotherapy at Würzburg University Hospital.[3] Shortly after that, in 2009, he was appointed W2 Professor of Psychiatry and Deputy Director of the Department of Psychiatry, Psychosomatics and Psychotherapy at Würzburg University Hospital.[1]
Since August 2014, Reif has been the head of the Department of Psychiatry, Psychosomatics and Psychotherapy at Johann Wolfgang Goethe University Frankfurt am Main.[2]
Reif's clinical interests include mood disorders – particularly suicide prevention, treatment-resistant depression, and bipolar disorder – and adult ADHD. His scientific focus is on translational psychiatry, aiming to understand mental disorders from molecule to neural system to disease, contributing to precise and individualized diagnosis and treatment.[2][4]
Selected publications
Reif has published over 600 scientific papers[5] and numerous book chapters.
- Ahrens, K. F., Neumann, R. J., Kollmann, B., Plichta, M. M., Lieb, K., Tüscher, O., & Reif, A. (2021). Differential impact of COVID-related lockdown on mental health in Germany. World psychiatry : official journal of the World Psychiatric Association (WPA), 20(1), 140–141. doi:10.1002/wps.20830
- Penninx, B. W., Pine, D. S., Holmes, E. A., & Reif, A. (2021). Anxiety disorders. Lancet, 397(10277), 914–927. doi:10.1016/S0140-6736(21)00359-7
- Gururajan, A., Reif, A., Cryan, J. F., & Slattery, D. A. (2019). The future of rodent models in depression research. Nature reviews. Neuroscience, 20(11), 686–701. doi:10.1038/s41583-019-0221-6
- van Hulzen, K., Scholz, C. J., Franke, B., Ripke, S., Klein, M., McQuillin, A., Sonuga-Barke, E. J., PGC ADHD Working Group, Kelsoe, J. R., Landén, M., Andreassen, O. A., PGC Bipolar Disorder Working Group, Lesch, K. P., Weber, H., Faraone, S. V., Arias-Vasquez, A., & Reif, A. (2017). Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis. Biological psychiatry, 82(9), 634–641. doi:10.1016/j.biopsych.2016.08.040
- Reif, A., Herterich, S., Strobel, A., Ehlis, A. C., Saur, D., Jacob, C. P., Wienker, T., Töpner, T., Fritzen, S., Walter, U., Schmitt, A., Fallgatter, A. J., & Lesch, K. P. (2006). A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Molecular psychiatry, 11(3), 286–300. doi:10.1038/sj.mp.4001779
Selected honors and awards
(Source:[1])
- 2004: Collegium Internationale Neuro-Psychopharmacologicum (CINP): Rafaelsen Young Investigators Award
- 2004: Lundbeck Institute Neuroscience Foundation Sponsorship Award
- 2006: European College of Neuropsychopharmacology: ECNP Fellowship Award[6]
- 2007: Young Psychiatrists Fellowship Award
- 2008: Essex Research Award[7]
- 2009: Early Career Investigator Award
Selected memberships and appointments
- since 2013: Treasurer of the German Society for Bipolar Disorder[8]
- since 2016: President of the German Alliance against Depression (Bündnis gegen Depression), Frankfurt am Main
- since 2016: Executive Committee Member of the German Association for Psychiatry, Psychotherapy and Psychosomatics[9]
- since 2019: Executive Committee Member (since 2022 President-Elect) of the European College of Neuropsychopharmacology (ECNP)[10]
- 2019–2021: Head of the ECNP Congress Scientific Program Committee[11]
References
- ↑ 1.0 1.1 1.2 CV on the ECNP Website
- ↑ 2.0 2.1 2.2 2.3 Profile on the website of the Department of Psychiatry, Psychosomatic Medicine and Psychotherapy (University Hospital Frankfurt) (In German)
- ↑ Press release 28.04.2014: "Hohes Leistungsniveau bei Bipolaren Störungen" (In German)
- ↑ ECNP Interview with Andreas Reif
- ↑ Pubmed entries for Andreas Reif
- ↑ ECNP Fellowship Awards 2006
- ↑ Dtsch Arztebl 2008; 105(50): A-2714 / B-2302 / C-2218 (in German)
- ↑ Executive Committee Members of the German Society for Bipolar Disorder(in German)
- ↑ Executive Committee of the German Association for Psychiatry, Psychotherapy and Psychosomatics
- ↑ The ECNP Executive Committee
- ↑ Information on the ECNP Scientific Program Committee
External links
- Profile on the website of the Interdisciplinary Center for Neuroscience Frankfurt (ICNF) (in German)
This article "Andreas Reif" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Andreas Reif. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
